NM_004628.5:c.658C>T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004628.5(XPC):c.658C>T(p.Arg220*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,612,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R220R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004628.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| XPC | NM_004628.5 | c.658C>T | p.Arg220* | stop_gained | Exon 6 of 16 | ENST00000285021.12 | NP_004619.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| XPC | ENST00000285021.12 | c.658C>T | p.Arg220* | stop_gained | Exon 6 of 16 | 1 | NM_004628.5 | ENSP00000285021.8 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000202 AC: 5AN: 247090 AF XY: 0.0000149 show subpopulations
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460644Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 14AN XY: 726452 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Xeroderma pigmentosum, group C Pathogenic:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Xeroderma pigmentosum Pathogenic:1
Variant summary: XPC c.658C>T (p.Arg220X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2e-05 in 247090 control chromosomes. c.658C>T has been reported in the literature in multiple individuals affected with Xeroderma Pigmentosum and has also been subsequently cited by others (example, Chavanne_2000, Soufir_2010, Hadj-Rabia_2013, Fassihi_2016, McDaniel_2007, Rivera-Begeman_2007). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (Chavanne_2000). The most pronounced variant effect results in <10% of normal activity in repair synthesis ability. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg220*) in the XPC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XPC are known to be pathogenic (PMID: 23173980, 25256075). This variant is present in population databases (rs745679643, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum (PMID: 10766188). ClinVar contains an entry for this variant (Variation ID: 550020). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at